Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04337931
Title A Study to Evaluate APX005M in Subjects With Unresectable or Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Apexigen, Inc.
Indications

melanoma

Therapies

APX005M

Age Groups: adult | senior
Covered Countries


No variant requirements are available.